Evidence-based medicine: Watching out for its friends

Howard Brody, Franklin G. Miller, Elizabeth Bogdan-Lovis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

An old joke states that one need not worry about one's enemies, but may be in danger from one's friends. We review a number of "enemies" and "friends" of evidence-based medicine (EBM). To understand where these enemies and friends have come from, it is important to see how the rise of EBM has created shifts in power, especially within academic medicine. Attacks from "enemies"-especially the criticism that EBM amounts to overturning a medicine of the individual in favor of an undesirable population medicine-tend to reflect misunderstandings of EBM, or of the degrees of uncertainty inherent in medicine itself, rather than substantive criticisms. The activities of three categories of so-called friends might well give EBM an undesirable reputation. These "friends" are the practitioners of a crude version of EBM (uncritical acceptance of randomized controlled trials while rejecting all other forms of evidence), commercial sponsors of clinical trials whose biases distort the available evidentiary base, and bureaucrats who employ EBM practices in the service of inequitable rationing of health resources.

Original languageEnglish (US)
Pages (from-to)570-584
Number of pages15
JournalPerspectives in Biology and Medicine
Volume48
Issue number4
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Evidence-Based Medicine
medicine
Medicine
Health Resources
Evidence-Based Practice
Evidence-based Medicine
Uncertainty
Randomized Controlled Trials
Clinical Trials
Enemy
clinical trials
uncertainty
Population

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Medicine (miscellaneous)
  • History

Cite this

Brody, H., Miller, F. G., & Bogdan-Lovis, E. (2005). Evidence-based medicine: Watching out for its friends. Perspectives in Biology and Medicine, 48(4), 570-584.

Evidence-based medicine : Watching out for its friends. / Brody, Howard; Miller, Franklin G.; Bogdan-Lovis, Elizabeth.

In: Perspectives in Biology and Medicine, Vol. 48, No. 4, 09.2005, p. 570-584.

Research output: Contribution to journalArticle

Brody, H, Miller, FG & Bogdan-Lovis, E 2005, 'Evidence-based medicine: Watching out for its friends', Perspectives in Biology and Medicine, vol. 48, no. 4, pp. 570-584.
Brody H, Miller FG, Bogdan-Lovis E. Evidence-based medicine: Watching out for its friends. Perspectives in Biology and Medicine. 2005 Sep;48(4):570-584.
Brody, Howard ; Miller, Franklin G. ; Bogdan-Lovis, Elizabeth. / Evidence-based medicine : Watching out for its friends. In: Perspectives in Biology and Medicine. 2005 ; Vol. 48, No. 4. pp. 570-584.
@article{d1875bd8120447e89880ff9e7ff00041,
title = "Evidence-based medicine: Watching out for its friends",
abstract = "An old joke states that one need not worry about one's enemies, but may be in danger from one's friends. We review a number of {"}enemies{"} and {"}friends{"} of evidence-based medicine (EBM). To understand where these enemies and friends have come from, it is important to see how the rise of EBM has created shifts in power, especially within academic medicine. Attacks from {"}enemies{"}-especially the criticism that EBM amounts to overturning a medicine of the individual in favor of an undesirable population medicine-tend to reflect misunderstandings of EBM, or of the degrees of uncertainty inherent in medicine itself, rather than substantive criticisms. The activities of three categories of so-called friends might well give EBM an undesirable reputation. These {"}friends{"} are the practitioners of a crude version of EBM (uncritical acceptance of randomized controlled trials while rejecting all other forms of evidence), commercial sponsors of clinical trials whose biases distort the available evidentiary base, and bureaucrats who employ EBM practices in the service of inequitable rationing of health resources.",
author = "Howard Brody and Miller, {Franklin G.} and Elizabeth Bogdan-Lovis",
year = "2005",
month = "9",
language = "English (US)",
volume = "48",
pages = "570--584",
journal = "Perspectives in Biology and Medicine",
issn = "0031-5982",
publisher = "Johns Hopkins University Press",
number = "4",

}

TY - JOUR

T1 - Evidence-based medicine

T2 - Watching out for its friends

AU - Brody, Howard

AU - Miller, Franklin G.

AU - Bogdan-Lovis, Elizabeth

PY - 2005/9

Y1 - 2005/9

N2 - An old joke states that one need not worry about one's enemies, but may be in danger from one's friends. We review a number of "enemies" and "friends" of evidence-based medicine (EBM). To understand where these enemies and friends have come from, it is important to see how the rise of EBM has created shifts in power, especially within academic medicine. Attacks from "enemies"-especially the criticism that EBM amounts to overturning a medicine of the individual in favor of an undesirable population medicine-tend to reflect misunderstandings of EBM, or of the degrees of uncertainty inherent in medicine itself, rather than substantive criticisms. The activities of three categories of so-called friends might well give EBM an undesirable reputation. These "friends" are the practitioners of a crude version of EBM (uncritical acceptance of randomized controlled trials while rejecting all other forms of evidence), commercial sponsors of clinical trials whose biases distort the available evidentiary base, and bureaucrats who employ EBM practices in the service of inequitable rationing of health resources.

AB - An old joke states that one need not worry about one's enemies, but may be in danger from one's friends. We review a number of "enemies" and "friends" of evidence-based medicine (EBM). To understand where these enemies and friends have come from, it is important to see how the rise of EBM has created shifts in power, especially within academic medicine. Attacks from "enemies"-especially the criticism that EBM amounts to overturning a medicine of the individual in favor of an undesirable population medicine-tend to reflect misunderstandings of EBM, or of the degrees of uncertainty inherent in medicine itself, rather than substantive criticisms. The activities of three categories of so-called friends might well give EBM an undesirable reputation. These "friends" are the practitioners of a crude version of EBM (uncritical acceptance of randomized controlled trials while rejecting all other forms of evidence), commercial sponsors of clinical trials whose biases distort the available evidentiary base, and bureaucrats who employ EBM practices in the service of inequitable rationing of health resources.

UR - http://www.scopus.com/inward/record.url?scp=26844460178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844460178&partnerID=8YFLogxK

M3 - Article

C2 - 16227668

AN - SCOPUS:26844460178

VL - 48

SP - 570

EP - 584

JO - Perspectives in Biology and Medicine

JF - Perspectives in Biology and Medicine

SN - 0031-5982

IS - 4

ER -